Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth

被引：0
|
作者：
Yizheng Zhang
Chuchu Zhang
Jiehan Li
Meimei Jiang
Shuning Guo
Ge Yang
Lingling Zhang
Feng Wang
Shiqi Yi
Jiangang Wang
Yang Fu
Yingjie Zhang
机构：
[1] The Third Xiangya Hospital,Department of Health Management
[2] Central South University,Department of Gastrointestinal Surgery
[3] The First Affiliated Hospital of Zhengzhou University,School of Biomedical Sciences
[4] Hunan University,Department of Ophthalmology
[5] The First Affiliated Hospital of Zhengzhou University,Department of Laboratory Medicine
[6] The Third Xiangya Hospital,Department of Gastroenterology
[7] Central South University,Center for Reproductive Medicine
[8] The Tenth People’s Hospital of Shanghai,College of Biology
[9] Tongji University,Department of Pathology and Neuropathology
[10] The First Affiliated Hospital of Zhengzhou University,undefined
[11] Hunan University,undefined
[12] University Hospital Tuebingen,undefined
来源：
Cell Communication and Signaling | / 20卷
关键词：
AKT; p53; Parthanatos; Cell death; SIRT6; Colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] p53 Status in Stromal Fibroblasts Modulates Tumor Growth in an SDF1-Dependent Manner
    Addadi, Yoseph
    Moskovits, Neta
    Granot, Dorit
    Lozano, Guillermina
    Carmi, Yaron
    Apte, Ron N.
    Neeman, Michal
    Oren, Moshe
    CANCER RESEARCH, 2010, 70 (23) : 9650 - 9658
  • [32] BaZiBuShen alleviates altered testicular morphology and spermatogenesis and modulates Sirt6/P53 and Sirt6/NF-κB pathways in aging mice induced by D-galactose and NaNO2
    Li, Lin
    Chen, Beibei
    An, Tian
    Zhang, Hao
    Xia, Bingke
    Li, Rui
    Zhu, Ruyuan
    Tian, Yimiao
    Wang, Lili
    Zhao, Dandan
    Mo, Fangfang
    Li, Yu
    Yang, Ge
    Orekhov, Alexander N.
    Prentki, Marc
    Zhang, Dongwei
    Jiang, Guangjian
    Zhu, Xiaofeng
    JOURNAL OF ETHNOPHARMACOLOGY, 2021, 271
  • [33] FBXL6 degrades phosphorylated p53 to promote tumor growth
    Li, Yajun
    Cui, Kaisa
    Zhang, Qiang
    Li, Xu
    Lin, Xingrong
    Tang, Yi
    Prochownik, Edward, V
    Li, Youjun
    CELL DEATH AND DIFFERENTIATION, 2021, 28 (07): : 2112 - 2125
  • [34] FBXL6 degrades phosphorylated p53 to promote tumor growth
    Yajun Li
    Kaisa Cui
    Qiang Zhang
    Xu Li
    Xingrong Lin
    Yi Tang
    Edward V. Prochownik
    Youjun Li
    Cell Death & Differentiation, 2021, 28 : 2112 - 2125
  • [35] hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase
    Vaziri, H
    Dessain, SK
    Eagon, EN
    Imai, SI
    Frye, RA
    Pandita, TK
    Guarente, L
    Weinberg, RA
    CELL, 2001, 107 (02) : 149 - 159
  • [36] P53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis
    de Belle, I
    Huang, RP
    Fan, Y
    Liu, CT
    Mercola, D
    Adamson, ED
    ONCOGENE, 1999, 18 (24) : 3633 - 3642
  • [37] p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis
    Ian de Belle
    Ruo-Pan Huang
    Yan Fan
    Chaoting Liu
    Dan Mercola
    Eileen D Adamson
    Oncogene, 1999, 18 : 3633 - 3642
  • [38] ASF1a inhibition induces p53-dependent growth arrest and senescence of cancer cells
    Wu, Yujiao
    Li, Xidan
    Yu, Jingya
    Bjorkholm, Magnus
    Xu, Dawei
    CELL DEATH & DISEASE, 2019, 10 (2)
  • [39] ASF1a inhibition induces p53-dependent growth arrest and senescence of cancer cells
    Yujiao Wu
    Xidan Li
    Jingya Yu
    Magnus Björkholm
    Dawei Xu
    Cell Death & Disease, 10
  • [40] Icaritin induces ovarian cancer cell apoptosis through activation of p53 and inhibition of Akt/mTOR pathway
    Gao, Lvfen
    Chen, Ming
    Ouyang, Yuan
    Li, Ruobin
    Zhang, Xian
    Gao, Xuesong
    Lin, Shaoqiang
    Wang, Xiaoyu
    LIFE SCIENCES, 2018, 202 : 188 - 194
12345